UCSF

Certificate Programs

Research Certificate Program

Purpose

The UCSF Research Certificate Program is a longitudinal research training program that provides formalized growth opportunities to strengthen clinical research abilities and develop skills necessary to understand the principles of research design, statistical analysis, and project development.

Program Goals

  • Develop effective project and time management skills

  • Acquire skills for designing and interpreting clinical research

  • Provide resident and preceptor development opportunities
  • Produce publishable resident research projects

Mentorship

  • Residents work closely with their research preceptors and teams throughout the year. In addition, each resident is paired with a Research Advisor who are clinical pharmacists with advanced training in statistical analysis. 

Program Requirements

Designing Clinical Research Course

  • Attend lectures and small-group sessions within an interprofessional curriculum
  • Develop an IRB-approved research protocol

Resident Research Series

  • Attend one-hour seminars pertaining to IRB Submissions, REDCap, methodologies and abstracts, poster development, STATA and data analysis, building tables and graphs, presentation skills, and manuscript writing

Manuscript

  • Prepare a manuscript suitable for publication

Research Days

  • Nine dedicated research days allocated throughout the residency year

Research Portfolio

  • Develop and maintain a research project plan, portfolio, and evaluation strategy

Research Dissemination

  • Residents are highly encouraged to disseminate their research work. To achieve a Research Certificate, residents are required to conduct a peer-review with a preceptor, and to submit a manuscript for publication. There are many opportunities to publish throughout the year, and the submission does not necessarily need to be the resident's research project, but may also include case reports, letters to the editor and other editorials.
  • Check out the PDF iconUCSF Pharmacy Residency Publications (or scroll below)
Publications

2022

  • Kaip EA, Nguyen NY, Cocohoba JM. Antiretroviral Therapy Efficacy Post-Bariatric Weight Loss Surgery: A Case Series of Persons Living with Human Immunodeficiency Virus. Obes Surg. 2022 Feb 16. doi: 10.1007/s11695-022-05956-7. Epub ahead of print. PMID: 35171391.
  • Lee A, Coralic Z. Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department. Annals of Pharmacotherapy. 2022 Feb;56(2):151-154.
  • Leung T, Kedzior S, Moore K, Bierman J, Coralic Z. Intermittent versus continuous infusion dosing of intravenous proton pump inhibitors for upper gastrointestinal bleeding. Annals of Pharmacotherapy 2022;1-6. https://doi.org/10.1177/10600280211073936
  • Coralic Z, Rader (Staub) ES, Vinson DR, Wilson MP. Haloperidol versus ziprasidone with concomitant medications and other predictors of physical restraint duration in the emergency department. Journal of Emergency Medicine 2022;1-11.
  • On S, Rath CG, Lan M, Wu B, Lau KM, Cheung E, Alegria W, Young R, Tan M, Kim C, Phun J, Patel N, Mannis G, Logan AC, Kennedy V, Goodman A, Taplitz RA, Young PA, Wen R, Saunders IM. Characterization of Infections in Patients with Acute Myeloid Leukemia Receiving Venetoclax and a Hypomethylating Agent. Br J Haematol. 2022. DOI: 10.1111/bjh.18051.
  • Rath CG, Lapetina PE, Reed J, Vogt E, Brown A. Roadmap to resilience: incorporating a wellness program into the pharmacy residency curriculum. Currents in Pharmacy Teaching and Learning 2022; Accepted February 2022.
  • Vo K, Guan T, Banerjee R, Lo M, Young R, Shah N. Complete response following treatment of plasma cell leukemia with venetoclax and dexamethasone: a case report. J Oncol Pharm Pract 2022. Epub ahead of print. DOI: 10.1177/10781552221074269.

2021

  • Huynh C, Lui J, Behbahani V, Thompson A, Morris A, Baumgartner L. Pre Versus Post Implementation of a Pharmacologic Antishivering Protocol During Targeted Temperature Management Following Cardiac Arrest. Neurocrit Care 2021 [epub]. doi: 10.1007/s12028-021-01327-9
  • Lee A, Oley F, Lo M, et al. Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors. Thrombosis Research. 2021;208:148-155.
  • Kotis D, Rath C. Strengthening our defenses: The role of the health-system pharmacist in cybersecurity management. J Am Coll Clin Pharm. 2021;4:662-663.
  • Tam AH, Jung Y, Young R, Huang CY, Wolf J, Shah N, Wong SW, Martin TG, Lo M. Evaluation of subcutaneous daratumumab injections in the ambulatory care setting. J Oncol Pharm Pract. 2021 Oct 14:10781552211046911. doi: 10.1177/10781552211046911. Epub ahead of print. PMID: 34647506.

2020

  • Cheung E, Borno H. The limitations of today’s clinical guidance: Atypical femoral fracture and long-term bone-modifying agents in the oncology setting. Journal of Oncology Pharmacy Practice 2020; 26(5):1180-1189.
  • Narayan R, Galligan D, Lazar AA, Kim S, Fong R, Tan M, Lo M, Arora S, Shah N, Wong SW, Martin T, Wolf J, Modified Hyper-CVAD with Proteasome Inhibition for Multiple Myeloma: A Single Center Retrospective Analysis. Clinical Lymphoma, Myeloma and Leukemia 2020 [epub 7/28/20].
  • Nguyen NY, Okeke E, Anglemyer A, Brock T. Identifying Perceived Barriers to Human Papillomavirus Vaccination as a Preventative Strategy for Cervical Cancer in Nigeria. Annals of Global Health. 2020; 86(1),118. (http://doi.org/10.5334/aogh.2890).
  • Yu CZ, Myers SR, Faldasz JD. Simulated comparison of a bayesian clinical decision support system versus standard of care for achieving gentamicin pharmacokinetic targets in neonates. Pediatr Infect Dis J 2020;39(4):313-317.

2019

  • Bouajram RH, Bhatt K, Croci R, et al. Incidence of Dexmedetomidine Withdrawal in Adult Critically Ill Patients: A Pilot Study. Crit Care Explor. 2019;1(8):e0035. Published 2019 Aug 9. doi:10.1097/CCE.0000000000000035
  • Gruenberg K, Brock T, MacDougall C. Longitudinal Associations Between Grit, Academic Outcomes, and Residency Match Rates Among Pharmacy Students. Am J Pharm Educ. 2019;83(6):6947. doi:10.5688/ajpe6947
  • Japs KL, Dennehy C, Stoffella S, Faldasz J, Bress J. Sources of drug information in neonatal guidelines of low- and middle-income countries. Int J Pharm Pract. 2019 Jun;27(3):322-324. doi: 10.1111/ijpp.12502. Epub 2019 Jan 2.
  • Lee S, Morris A, Kim S, Baumgartner L, Li F. Impact of quetiapine on QTc prolongation in critically ill patients. Ann Pharmacother 2019:53(7);705-710.
  • Ma D, Wong W, Aviado J, Rodriguez C, Wu H. Safety and tolerability of accelerated infliximab infusions in patients with inflammatory bowel disease. Am J Gastroenterol 2019;114(2):352-354.
  • Truong S, Park A, Kamalay S, Hung N, Meyer J, Nguyen N, Momenzadeh A. Glycemic Control in Adult Surgical Patients Receiving Regular Insulin Added to Parenteral Nutrition vs Insulin Glargine: A Retrospective Chart Review. Nutr Clin Pract. 2019;34(5):775-782.
  • Morris A, Young G, Li F, Takamoto P, Baumgartner L. High-fidelity simulation increases pharmacy resident perceived competence during medical emergencies. Curr Pharm Teach Learn 2019:11(10)1016-1021.

2018

  • Avdagic K, Geier M, Coralic Z, Finley P. Evaluation of the Impact of a Multimodal Intervention on Prescribing Patterns of Sedative-Hypnotics in a Behavioral Health System. Prim Care Companion CNS Disord 2018; May 31;20(3):18m02269.
  • Vitt JR, Do LV, Shah NH, Fong G, Nguyen NY, Kim AS. Before-After Study of an Electronic Order Set for Reversal of Vitamin K Antagonist-Associated Intracerebral Hemorrhage. Neurohospitalist. 2018; 8(1):18-23. (doi: 10.1177/1941874417714706).
  • Garcia JA, Baumgartner L, Conrad M, Morris A, Takamoto P, Tasaka C. Reduced versus conventional dose insulin for hyperkalemia treatment. Journal of Pharmacy Practice 2018:1-5.
  • Kang A, Thompson A, Rau J, Pollock A. Effects of clinical decision support and pharmacist prescribing authority on a therapeutic interchange program. AJHP 2018;17(3)S77-S81.

2016

  • Dao B, Ho H, Quintal L. Combination pertuzumab, trastuzumab, and taxane for metastatic breast cancer after first progression: a single institution's experience. Journal of Oncology Pharmacy Practice 2016; 22(2):261-4
  • Hsu O, Tsourounis C, Chan LL, Dennehy C. Chinese Herb Use by Patients at a San Francisco Chinatown Public Health Center. J Altern Complement Med. 2016 Sep;22(9):751-6. doi: 10.1089/acm.2015.0288. Epub 2016 Jun 29.
  • Narayanan N, Gross AK, Pintens M, Fee C, MacDougall C. Effect of an electronic medical record alert for severe sepsis among ED patients. Am J Emerg Med. 2016;34(2):185-188. doi:10.1016/j.ajem.2015.10.005

2015

  • Tan M, Fong R, Lo M, Young R. Lenalidomide and secondary acute lymphoblastic leukemia: A case series. Hematological Oncology. 2015;35(1):130-134
  • Tan M, Quintal L. Pembrolizumab: A Novel Anti-PD-1 Monoclonal Antibody for Treatment of Metastatic Melanoma. Journal Clinical Pharmacy and Therapeutics 2015;40(5):504-507.

 

Posters & Platform Presentations

2022

  • Gordon R, Yen B, Dewey K, Jariwala R, Kukreja J, Hays S, Singer J, Florez R. Evaluation of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Recipients. Oral Presentation at the American Transplant Congress Annual Meeting. June 2022. Boston, MA.

2021

  • Guan T, Lo M, Young R, Boulbol F, Mouanoutoua H, Chu R, Ai W, Abdulhaq H, Fakhri B. Evaluation of Pulmonary Toxicities in Lymphoma Patients Receiving Brentuximab. Poster presented at the 63rd Annual American Society of Hematology Annual Meeting. December 2021. Atlanta, GA. Virtual.
  • Kaip E, Shippey E, MacDougall C. (September 2021). Characterizing national antifungal use trends in hospitalized patients. Poster presented at IDWeek. September 2021. Virtual.
  • Le T, Shoji J, Phillips J, Quan D. Tolerability of De Novo and Conversion Belatacept Regimens in Kidney Transplantation. Oral Presentation at the American Transplant Congress Annual Meeting. June 2021. Virtual
  • Nguyen T, Ng A, Lucas SS, Nicolau I, McCammond A, Robinson JD. Antithrombin III replacement following cardiac surgery in children with congenital heart disease. Platform presentation at the Pediatric Pharmacy Association Annual Meeting. April 2021. Virtual.

2020

  • Bouajram R, Baumgartner L, Bhatt K, Thompson A, Puntillo K. Validation of an Iatrogenic Withdrawal Assessment Tool for the Intensive Care Unit. Poster presented at the Society of Critical Care Medicine Annual Congress. December 2020. Orlando, FL.
  • Lazo J, Viduya J, Dewey K, Florez R, e al. Genotyping Predicts Osteoporosis Risk After Lung Transplantation. Oral Presentation at the International Society of Heart and Lung Transplantation International Annual Meeting. April 2020. Virtual
  • Lee A, Oley F, Lo M, et al. Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors. Poster presented at the 62nd Annual American Society of Hematology Annual Meeting. December 2020. Virtual.
  • Staub ES, Thompson A, Agustin J, Rashidi S, Shieh J, Croci R, Li F, Gross AK. Effect of restarting psychotropic home medications on the incidence of intensive care unit delirium. Poster presented at Society of Critical Care Medicine Annual Congress. February 2020. Orlando, FL.

2019

  • Franck L, Stoffella S, Baggett K, Bisgaard R, Lucas SS, Sun Y. Post-implementation assessment of the Withdrawal Evaluation of Analgesia in Neonates (WEAN) protocol. Poster presented at: ISPP – Children and Families as Partners in Pain Management 12th International Symposium on Pediatric Pain. June 2019. Basel, Switzerland.
  • Barnes A, Calabrese DR, Henricksen E, Florez R, Dewey KW, et al. Polymorphisms in Mycophenolate Mofetil Glucuronidation Gene Are Associated with Leukopenia and Decreased CLAD-Free Survival. Oral Presentation at the American Transplant Congress Annual Meeting. June 2019. Boston, MA.
  • Bouajram R, Thompson A, Puntillo K, Ramsay J, Bhatt K. Incidence of Dexmedetomidine Withdrawal Symptoms After Prolonged Dexmedetomidine Infusion. Poster presented at: Society of Critical Care Medicine Annual Congress. February 2019. San Diego, CA.
  • Bhatt K, Thompson A, Jia S, Puntillo K, Ramsay J, Bouajram R. Effects of a Clonidine Taper on the Incidence of Dexmedetomidine Withdrawal Symptoms. Poster presented at: Society of Critical Care Medicine Annual Congress. February 2019. San Diego, CA.
  • Thompson A, Dacey K, Schell-Chaple H, Liu K, Gross K. Scheduled Enteral Phosphate Prevents Hypophosphatemia in Continuous Renal Replacement Therapy. Poster presented at: Society of Critical Care Medicine Annual Congress. February 2019. San Diego, CA.
  • Han A, Nguyen NY, Hung N, Kamalay S. Impact of a Bariatric Surgery Clinic-Based Pharmacist on Length of Stay and Patient Satisfaction. Poster presented at: 36th Annual Obesity Week (ASMBS). November 2019. Las Vegas, NV.
  • Joyal K, Chi A, Faldesz J. Evaluation of vancomycin dosing in end stage liver disease. ACCP Annual Meeting, October 2019. New York, NY.
  • Rashidi S, Shieh J, Augustin J, Thompson A, Li F, Gross K, Staub E. Expanding pharmacy resident research capacity through integration of introductory experiential students into a prospective research study: a novel application of the layered learning model. Poster presented at: ASHP Midyear Clinical Meeting. December 2019. Las Vegas, NV.
  • Shieh J, Rashidi S, Thompson A, Gross K, Staub E. Perceived benefits of utilizing introductory pharmacy practice experience (IPPE) students to support pharmacy resident scholarly activities. Poster presented at: ASHP Midyear Clinical Meeting. December 2019. Las Vegas, NV.

2018

  • Henricksen E, Calabrese D, Florez R, Dewey K, et al. Polymorphisms in the KCNJ11 Gene are Associated with New Onset Diabetes After Lung Transplantation. Oral Presentation at the International Society of Heart and Lung Transplantation International Annual Meeting. April 2018 Nice, France.
  • Ky TQ, Stoffella S, Scarpace Lucas S, Bisgaard R, Henderson G, Sun Y, Franck L. Clinical and Statistical Assessment of the Withdrawal Evaluation of Analgesia for Neonates (WEAN) Protocol. Poster presented at: California Society of Health-System Pharmacists Seminar. October 2018. San Diego, CA.
  • Gross AK, Chan ER, Smith JJ, Thompson A. Sustainability in Quality Improvement: Reducing Quetiapine Continuation at Transitions of Care. Poster presented at: American Delirium Society Annual Meeting. June 2018. San Francisco, CA. Winner, Best Clinical/Implementation Poster.

2017

  • Lee S, Kim S, Baumgartner L, Li F, Morris AA. Impact of quetiapine on QTc prolongation in critically ill patients. Poster presented at: Society of Critical Care Medicine Annual Congress. January 2017. Honolulu, HI.
  • Smith JJ, Gross AK, Chang J, Zhu JM, Rennke S, Thompson A. A bundled intervention for reducing quetiapine continuation at transitions of care. Poster presented at: Society of Critical Care Medicine Annual Congress. February 2017. Honolulu, HI.
  • Kim K, Thompson A, Wang D, Ramsay J, Bouajram R. Enteral Clonidine Taper to Transition Adult ICU Patients Off of Prolonged Dexmedetomidine Infusions. Poster presented at: California Society of Health-System Pharmacists Seminar. October 2017. Anaheim, CA.

2016

  • Vitt JR, Do LV, Shah NH, Fong G, Nguyen NY, Kim AS. Before-After Study of an Electronic Order Set for Reversal of Vitamin K Antagonist-Associated Intracerebral Hemorrhage. Poster presented at: 14th Annual Neurocritical Care Society Meeting. September 2016. Washington D.C.

2015

  • Narayanan N, Gross AK, Pintens M, Fee C, MacDougall C. Effect of an electronic medical record alert for severe sepsis among emergency department patients. Poster presented at: Society of Critical Care Medicine Annual Congress. February 2015. Phoenix, AZ.

Teaching Certificate Program

Purpose

The UCSF Teaching Certificate Program is jointly sponsored by UCSF Medical Center and UCSF School of Pharmacy. The program is designed to support the development of residents in the design and conduct of small group teaching, large group teaching, and experiential education.

Program Goals

  • Provide effective medication and practice-related education to patients, caregivers, healthcare professionals, students, and the public
  • Effectively employ preceptor roles when teaching students
  • Develop and practice a philosophy of teaching

Program Requirements

Teaching Workshops

  • Attend interactive seminars focused on building clinical teaching skills, positive learning climates, teaching philosophies, and more

Large Group Teaching

  • Develop and deliver a large-group session to student pharmacists
  • Provide a one-hour continuing pharmacist education (CPE) session

Small Group Teaching

  • Facilitate weekly small-group learning of therapeutic concepts for 10 weeks
  • Provide health education to the public through community outreach events
  • Provide health education to interprofessional healthcare providers

Interactive Teaching

  • Participate in oral exams associated with therapeutics courses
  • Conduct an Objective Structured Clinical Examination (OSCE) associated with applied patient care skills courses

Experiential Education

  • Co-precept IPPE and APPE students on clinical services

Teaching Portfolio

  • Develop and maintain a teaching portfolio, teaching philosophy, and evaluation strategy

Teaching Workshops

  • Academic Assessment
  • Case Writing
  • Clinical Teaching Skills and Effective Feedback
  • Learning Climate
  • Setting Goals and Expectations
  • Teaching Philosophy

Teaching Certificate Directors

Mandy Brown, PharmD, BCPS, BCCCP
PGY1 Residency Program Director
Critical Care Pharmacist, UCSF Medical Center
Assistant Clinical Professor, UCSF School of Pharmacy
533 Parnassus Avenue, Box 0622
San Francisco, California 94143
Katherine Gruenberg, PharmD, BCPS
Assistant Clinical Professor, UCSF School of Pharmacy
533 Parnassus Avenue, Box 0622
San Francisco, California 94143

Resident Wellness Program

Purpose

The Resident Wellness Program is in cooperation with the 'Resiliency Medicine Training Course: Immunizing for Stress' and focuses on the pillars of resilience, self-management and community to promote the health, happiness and success of trainees and the prevention of burnout.

Program Goals

  • Support pharmacy residents by providing strategies and techniques to become competent, caring and resilient clinicians

  • Promote proactive self-development and self-care behaviors for lifelong learning and performance improvement in both personal and professional lives

  • Obtain certification in Resiliency in Medicine, a nationally recognized evidence-based training program

Program Requirements

  • Attend interactive focused seminars offered on a monthly basis

  • Practice introspection techniques through written reflections and discuss in a collaborative manner

  • Develop a “Personal Mission Statement”

  • Teach and model resiliency skills to demonstrate completion of the certificate program

Example Seminars​

Self-Management
  • Curriculum Vitae and Letter Writing Workshop
  • Emotional Intelligence
  • Myers Briggs Type Indicator
  • Strengths Finder
  • Time Management: Setting the Year Up for Success
Resilience
  • Imposter Syndrome
  • Resiliency in Medicine: Meditation, Gratitude, Internal Narrative
Community
  • Team Building Activities

DEI Champion Training

Purpose

At UCSF, we're committed to building a broadly diverse community, nurturing a culture that is welcoming and supportive, and engaging diverse ideas for the provision of culturally competent education, discovery, and patient care. All pharmacy residents participate in Diversity, Equity and Inclusion (DEI) Champion training, sponsored by UCSF School of Medicine. The goal of DEI Champion training is to increase awareness and skills for clinical teachers so that they can address bias and discrimination when and where it happens. The training includes education on implicit biases and microaggressions, coaching in skills related to addressing these issues, and training in how to apply thoughtful, active listening and empathy to support a more diverse, equitable, and inclusive environment.

Program Goals

  • Recognize bias and discrimination in the learning environment;
  • Use a shared language to talk about bias and discrimination with students;
  • Implement skills to address bias and discrimination; and
  • Apply practical tools for addressing bias and discrimination in their day-to-day teaching encounters.

Program Requirements

The training consists of ~45 minutes of pre-work, followed by two 3-hour interactive sessions. During the training, participants apply new skills in a variety of case-based scenarios. They also participate in an assessment of awareness, comfort, and confidence using the skills learned. PGY1 Pharmacy residents are provided dedicated time to complete the DEI Champion training during either their Leadership & Management or Medication Use & Outcomes rotations.